Previous exposure to hormone replacement therapy and confounders in metabolic studies

Menopause

Volumn 8, Issue 4, 2001, Pages 281-285

  Sites, Cynthia K ^a,b   L'Hommedieu, Georgia D ^a   Brochu, Martin ^a   Poehlman, Eric T ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Diabetes mellitus; Hormone replacement therapy; Insulin sensitivity; Visceral fat

Indexed keywords

INSULIN;

ABDOMEN; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; INTERVERTEBRAL DISK; POSTMENOPAUSE; SUBCUTANEOUS FAT;

EID: 0034941865     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200107000-00010     Document Type: Article

References (24)

1. Menopause, central body fatness, and insulin resistance: Effects of hormone replacement therapy
2. Changes in energy balance and body composition at menopause: A longitudinal study
3. Relation of regional fat distribution to insulin sensitivity in postmenopausal women
4. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
5. Effects of hormone replacement therapy on weight, body composition, fat distribution and food intake in early postmenopausal women: A prospective study
6. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women
7. Effect of postmenopausal hormone replacement therapy on body weight and waist and hip girths
8. Insulin resistance and body fat distribution
9. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women
10. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: Effects on serum lipoproteins and glucose tolerance during 24 month follow up
11. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
12. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women
13. The effect of estradiol and a combined estradiol/progestogen preparation on insulin sensitivity in healthy postmenopausal women
14. Effect of menopausal status on body composition: Comparison of premenopausal and early postmenopausal women
15. Obesity related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women
16. Glucose clamp technique: A method for quantifying insulin secretion and resistance
17. A questionnaire for the assessment of leisure time physical activity questionnaires
18. Validation and comparison of eight physical activity questionnaires
19. Test-retest reliability of the Minnesota Leisure Time Physical Activity Questionnaire
20. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women
21. Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy
22. Effect of short-term medroxyprogesterone acetate on left ventricular mass: Role of insulin-like growth factor-1
23. Postmenopausal hormone use and risk for colorectal cancer and adenoma
24. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer